BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11293406)

  • 21. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
    J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, spectroscopic, structural and thermal characterizations of vanadyl(IV) adenine complex prospective as antidiabetic drug agent.
    El-Megharbel SM; Hamza RZ; Refat MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():850-64. PubMed ID: 25150436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands.
    Yuen VG; Caravan P; Gelmini L; Glover N; McNeill JH; Setyawati IA; Zhou Y; Orvig C
    J Inorg Biochem; 1997 Nov; 68(2):109-16. PubMed ID: 9336969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acids.
    Kawabe K; Sasagawa T; Yoshikawa Y; Ichimura A; Kumekawa K; Yanagihara N; Takino T; Sakurai H; Kojima Y
    J Biol Inorg Chem; 2003 Nov; 8(8):893-906. PubMed ID: 14551811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
    J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
    Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
    Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metallokinetic analysis of disposition of vanadyl complexes as insulin-mimetics in rats using BCM-ESR method.
    Yasui H; Takechi K; Sakurai H
    J Inorg Biochem; 2000 Feb; 78(3):185-96. PubMed ID: 10805174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oxovanadium(IV) complexes on nondiabetic and streptozotocin-diabetic rats.
    Krosniak M; Zachwieja Z; Filipek B; Zygmunt M; Grybos R
    Arch Pharm (Weinheim); 2001 Dec; 334(12):388-92. PubMed ID: 11852534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic study and trial for preparation of enteric-coated capsule containing insulinomimetic vanadyl compounds: implications for clinical use.
    Sakurai H; Fugono J; Yasui H
    Mini Rev Med Chem; 2004 Jan; 4(1):41-8. PubMed ID: 14754442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
    Kawabe K; Yoshikawa Y; Adachi Y; Sakurai H
    Life Sci; 2006 May; 78(24):2860-6. PubMed ID: 16337244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
    Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
    Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
    Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H
    Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
    Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
    J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of a vanadyl (IV) folate complex for the treatment of diabetes: spectroscopic, structural, and biological characterization.
    Naglah AM; Refat MS; Al-Omar MA; Bhat MA; AlKahtani HM; Al-Wasidi AS
    Drug Des Devel Ther; 2019; 13():1409-1420. PubMed ID: 31118576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats.
    Ramachandran B; Kandaswamy M; Narayanan V; Subramanian S
    Diabetes Obes Metab; 2003 Nov; 5(6):455-61. PubMed ID: 14617232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes.
    Cam MC; Cros GH; Serrano JJ; Lazaro R; McNeill JH
    Diabetes Res Clin Pract; 1993 May; 20(2):111-21. PubMed ID: 8375263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats.
    Ahmed El-Shazly S; Ahmed MM; Ibrahim ZS; Refat MS
    Int J Immunopathol Pharmacol; 2015 Jun; 28(2):227-39. PubMed ID: 25816395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization and antidiabetic properties of N(1)-2,4-dihydroxybenzylidene-N(4)-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV).
    Yanardag R; Demirci TB; Ulküseven B; Bolkent S; Tunali S; Bolkent S
    Eur J Med Chem; 2009 Feb; 44(2):818-26. PubMed ID: 18621448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.